Myomo (MYO) Non-Current Deferred Tax Liability (2024)

Myomo (MYO) reported Non-Current Deferred Tax Liability of $1.9 million for Q4 2024.

Myomo (MYO) Non-Current Deferred Tax Liability (2024) Analysis & Trends

Myomo has reported Non-Current Deferred Tax Liability for 1 years, with the latest figure at $1.9 million in Q4 2024.

For the quarter ending Q4 2024, Non-Current Deferred Tax Liability changed N/A year-over-year to $1.9 million; the trailing twelve-month figure through Dec 2024 stood at $1.9 million (changed N/A YoY), and the FY2024 full-year result was $1.9 million, changed N/A from the prior year.
Non-Current Deferred Tax Liability for Q4 2024 stood at $1.9 million.
The five-year high for Non-Current Deferred Tax Liability was $1.9 million in Q4 2024, with the low at $1.9 million in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn
10	Myomo	49.44 Mn	31.04 Mn	-

Download Data

Date	Value
Dec 31, 2024	1.87 Mn
Dec 31, 2024	1.87 Mn